By focusing on epigenetic alterations, particularly PRC1/Bmi‐1 deregulation, our present review does address a crucial and emerging area of cancer research, highlighting the significance of epigenetic factors in GBM pathogenesis. The gene discussed is BMI1; the disease is glioblastoma.